PCOS Is Now Called PMOS: What the Rename Means for Your Care

On May 12, 2026, an international consensus paper published in The Lancet officially renamed polycystic ovary syndrome to Polyendocrine Metabolic Ovarian Syndrome (PMOS). The rename was presented at the European Congress of Endocrinology in Prague, endorsed by the Endocrine Society, and is the result of an 11-year consensus process involving 22,000 patients and clinicians worldwide.

If you have a PCOS diagnosis, your condition has not changed. The cells, the labs, the symptoms, the treatment options, all carry forward. What changed is the name. But the name was doing real damage, and the new one is built to fix that. Here is what you need to know.

Why PCOS needed a new name

The word "polycystic" was always inaccurate. The condition is not fundamentally about cysts on the ovaries. Many people with PCOS never had cystic-pattern ovaries on imaging. Many people without PCOS have multifollicular ovaries that look similar on ultrasound. The cyst-centric framing pushed clinicians toward looking at the wrong thing and pushed patients toward thinking ovarian surgery was a treatment, which it is not.

The consequence of that misnaming, repeated for decades: delayed diagnosis (average 4 to 5 years between first symptom and diagnosis in Canada), fragmented care (people sent to gynecology when the primary driver was metabolic), and a quiet stigma around the word cystic that made the condition feel reproductive when it is whole-body.

What the new name captures

Polyendocrine Metabolic Ovarian Syndrome breaks the condition into three accurate descriptors.

Polyendocrine acknowledges that the condition involves multiple interacting hormones, not one. Insulin, androgens (testosterone, DHEA-S), and neuroendocrine signalling (luteinizing hormone, gonadotropin-releasing hormone) all play a role. Treatment has to address the picture, not chase a single number.

Metabolic recognizes that insulin resistance, weight resistance, elevated type 2 diabetes risk, and elevated cardiovascular disease risk are core features of the condition. They are not side effects. They are not consequences of obesity. They are part of the mechanism. The metabolic framing is what most current treatment guidelines already prioritize, and the new name aligns the language with the medicine.

Ovarian keeps the cycle and ovulation piece of the picture intact. Irregular cycles, anovulation, and the impact on fertility are still part of the diagnostic conversation. The word just no longer pretends that cysts are the central feature.

What stays the same

• The Rotterdam diagnostic criteria still apply. A diagnosis still requires two of three findings: irregular or absent ovulation, signs of high androgens (clinical or on labs), or polycystic-pattern ovaries on ultrasound.
• The treatment approach is unchanged. Metabolic-focused care including nutrition, targeted supplementation (myo-inositol, vitamin D, magnesium where appropriate), exercise, sleep, and stress management remains the foundation.
• Medication options including metformin and combined oral contraceptives where indicated remain on the table.
• If you already had a PCOS diagnosis, you do not need a new one. The label simply updates to PMOS over time.

What changes in clinical practice

Implementation rolls out over a three-year transition. The next major international guideline update in 2028 will use PMOS as the primary term. Electronic health records, billing codes, patient education materials, and continuing-education programs will follow.

In the meantime, expect both terms to appear interchangeably. Your family doctor, your Naturopathic Doctor, your endocrinologist, and your fertility clinic may use either name during the transition. They mean the same condition.

What this means for naturopathic care

Naturopathic care for PCOS / PMOS has always emphasized the metabolic and multi-system nature of the condition. The full hormonal investigation, the insulin-resistance focus, the cardiovascular-risk awareness, the inflammation work, none of that is new to naturopathic practice. The rename brings mainstream medicine closer to a framework that root-cause clinicians have been working with for years.

For Ontario patients seeking naturopathic support: nothing about how to find care or what to expect at your first appointment changes. Comprehensive history, full hormonal and metabolic labs, a 60-minute first appointment, a plan that addresses the underlying drivers rather than just managing symptoms. The label on the chart updates over time.

Why this matters beyond terminology

Naming matters in medicine. The wrong name has consequences. A teenager with irregular cycles, acne, and an elevated insulin level who hears you might have polycystic ovaries gets sent down a different diagnostic path than the same teenager who hears you might have a polyendocrine metabolic syndrome that involves your ovaries. The first framing routes care toward reproductive-system specialists. The second routes care toward a metabolic and whole-body workup, which is usually what is needed first.

For the 170 million women worldwide living with this condition, the rename is small. For the next generation of teenagers and young adults walking into clinics with these symptoms, the rename changes how they will be diagnosed, how quickly, and what they hear first. That is worth it.

If you have questions about your own diagnosis

If you have an existing PCOS diagnosis and want to talk through what the rename means for your care plan, or if you have symptoms that have not yet been investigated, our CONO-registered Naturopathic Doctors offer a free 15-minute call to walk through your specific situation. You can also take our free 2-minute symptom check to see how your pattern lines up with the diagnostic criteria. Both are linked from our PCOS / PMOS page.